Agios Pharmaceuticals | AGIO - Capitale Ordinario

Prezzo Delle Azioni
28.05
Cambio Giornaliero
0 0%
Mensile
-17.09%
Annuale
-9.34%
Q2 Previsione
24.78




Capitale Ordinario Cambiamento Data
AbbVie USD 1.77B 1.75B 2025-06
Agios Pharmaceuticals USD 59.34M 892K 2026-03
Alnylam Pharmaceuticals USD 132.38M 585K 2025-12
Amgen USD 539M 1000K 2025-12
Arrowhead Research USD 135.7M 2.44M 2025-09
Astellas Pharma JPY 1.79B 81K 2026-03
AstraZeneca USD 1.55B 73K 2026-03
Bayer EUR 982.42M 0 2025-12
Biogen USD 146.7M 200K 2025-09
BioMarin Pharmaceutical USD 192.3M 201K 2025-12
Bristol-Myers Squibb USD 2.04B 1.74B 2025-09
Daiichi Sankyo JPY 1.85B 9K 2025-12
Eli Lilly USD 946.83M 354.23M 2025-06
Exelixis USD 268.1M 2.03M 2025-09
Gilead Sciences USD 1.24B 1000K 2025-12
GlaxoSmithKline GBP 4.05B 20.6M 2026-03
Incyte USD 199.95M 1.49M 2026-03
Ionis Pharmaceuticals USD 165.9M 3.93M 2026-03
Merck USD 2.49B 15.79M 2025-09
Moderna USD 391M 2M 2025-09
Nektar Therapeutics USD 20.38M 20.36M 2025-12
Novartis USD 1.91B 10.64M 2025-12
Novartis USD 1.91B 10.64M 2025-12
Pfizer USD 5.69B 1000K 2025-09
Puma Biotechnology USD 5K 0 2024-06
Regeneron Pharmaceuticals USD 105M 300K 2026-03
Roche Holding CHF 795.62M 699.54K 2025-12
Sarepta Therapeutics USD 104.96M 196K 2025-12
Vertex Pharmaceuticals USD 254M 0 2025-12